KDL Biotech Ltd.

NSE: KOPDRUGS | BSE: 532291

₹2.14

up-down-arrow-0.11 (-4.89%)

As on 16-Mar-2015IST

Market cap

info icon

₹5 Cr

Revenue (TTM)

info icon

₹26 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

-0.1

Div. Yield

info icon

0 %

KDL Biotech Share Price

Compare

High: Low: Return:

High: Low: Return:

Max: Min:

Max: Min:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 2.14 High: 2.14

52 Week Range

Low: -- High: --

Liquidityliquidity

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹-17 Cr

  • ROEROE information

    0 %

  • ROCEROCE information

    -108.4 %

  • Industry P/EIndustry P/E information

    39.9

  • EV/EBITDAEV/EBITDA information

    -34.2

  • Debt to EquityDebt to Equity information

    -1

  • Book ValueBook Value information

    ₹--

  • EPSEPS information

    ₹-5.9

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    24,035,151

10 Years Aggregate

CFO

₹65.60 Cr

EBITDA

₹-42.25 Cr

Net Profit

₹-188.43 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
KDL Biotech
32.1 13.2 28.1 20.2 -17.8 -29.9 -21.5
BSE Sensex*
-8.8 0.6 1.8 -4.4 6.0 6.6 10.8
BSE Healthcare#
18.8 2.8 8.7 17.1 23.1 14.8 12.4
As on 16-Mar-2015  |  *As on 28-Aug-2026  |  #As on 28-Aug-2026
Company
2014
KDL Biotech
-15.2
BSE Sensex
29.9
BSE Healthcare
47.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
KDL Biotech
2.1 5.1 -- -14.2 -- -- -- -0.1
3,281.6 26,870.9 1,461.8 387.4 34.5 25.2 69.6 15.5
813.5 16,000.2 7,784.0 688.5 10.6 14 23.1 2.7
449.9 17,241.8 2,141.5 58.5 5.8 3.3 162.3 4.5
836.7 20,739.4 5,632.3 662.4 17.2 14.3 31.3 4.2
1,532.2 17,579.4 1,543.3 -48.6 3.6 -0.6 -- 3.0
218.7 29,103.3 9,205.3 -371.8 1.7 -3.8 -- 3.6
1,804.4 29,891.8 1,935.8 288.2 20.6 29.8 103.7 22.3
403.4 16,284.0 3,600.2 221.0 9.7 5.6 73.7 3.4
1,977.1 32,103.6 3,564.0 414.0 15.3 8.4 78.5 6.4

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

No Review & Analysis are available.

About KDL Biotech

Manufacture of allopathic pharmaceutical preparations

  • Incorporated

    1986

  • Chairman

    --

  • Managing Director

    Nalin Bamzai

  • Group

    Parijat

  • Headquarters

    Savroli, Maharashtra

  • Website

    www.kdlbiotech.com

FAQs for KDL Biotech

The share price of KDL Biotech Ltd is ₹2.14 (BSE) and ₹2.50 (NSE) as of 16-Mar-2015 IST. KDL Biotech Ltd has given a return of -17.78% in the last 3 years.

Since, TTM earnings of KDL Biotech Ltd is negative, P/E ratio is not available.
The P/B ratio of KDL Biotech Ltd is -0.05 times as on 16-Mar-2015, a 101 discount to its peers’ median range of 4.23 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2012
0.00
-0.15
2011
0.00
-0.31
2008
0.00
0.71
2004
0.00
0.60
2003
7.10
0.28

The 52-week high and low of KDL Biotech Ltd are Rs -- and Rs -- as of 29-Aug-2026.

KDL Biotech Ltd has a market capitalisation of ₹ 5 Cr as on 16-Mar-2015. As per SEBI classification, it is a company.

Before investing in KDL Biotech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...
loading...
loading...